Revvity (NYSE:RVTY) Issues FY 2025 Earnings Guidance

Revvity (NYSE:RVTY) updated its FY 2025 earnings guidance on Tuesday. The company provided earnings per share guidance of 5.000- for the period, compared to the consensus earnings per share estimate of 4.910. The company issued revenue guidance of $2.9 billion-$2.9 billion, compared to the consensus revenue estimate of $2.8 billion. Revvity also updated its Q4 2025 guidance to EPS.

Revvity Stock Down 0.5%

RVTY opened at $103.96 on Tuesday. Revvity has a 12 month low of $81.36 and a 12 month high of $128.29. The business has a 50-day moving average of $98.31 and a two-hundred day moving average of $94.09. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.75 and a quick ratio of 1.44. The stock has a market capitalization of $11.79 billion, a price-to-earnings ratio of 52.24, a price-to-earnings-growth ratio of 3.19 and a beta of 1.05.

Revvity (NYSE:RVTY) last announced its quarterly earnings data on Monday, October 27th. The company reported $1.18 earnings per share for the quarter, topping the consensus estimate of $1.14 by $0.04. Revvity had a net margin of 8.44% and a return on equity of 7.52%. The business had revenue of $698.95 million for the quarter, compared to analyst estimates of $699.75 million. During the same period in the prior year, the firm posted $1.28 EPS. The company’s revenue was up 2.2% on a year-over-year basis. Revvity has set its FY 2025 guidance at 4.900-5.000 EPS. On average, research analysts expect that Revvity will post 4.94 earnings per share for the current year.

Revvity Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, February 6th. Investors of record on Friday, January 16th will be issued a $0.07 dividend. The ex-dividend date is Friday, January 16th. This represents a $0.28 dividend on an annualized basis and a yield of 0.3%. Revvity’s dividend payout ratio (DPR) is presently 14.07%.

Revvity declared that its board has approved a share repurchase program on Monday, October 27th that permits the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization permits the company to repurchase up to 8.7% of its stock through open market purchases. Stock repurchase programs are generally an indication that the company’s board of directors believes its stock is undervalued.

Analyst Ratings Changes

A number of analysts recently issued reports on RVTY shares. Bank of America downgraded shares of Revvity from a “buy” rating to a “neutral” rating and set a $110.00 target price for the company. in a research report on Monday, December 15th. Wells Fargo & Company boosted their price objective on shares of Revvity from $102.00 to $107.00 and gave the stock an “equal weight” rating in a research note on Monday, December 15th. Evercore ISI reissued an “outperform” rating on shares of Revvity in a research note on Monday, January 5th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Revvity in a research report on Monday, December 29th. Finally, Robert W. Baird raised their price objective on Revvity from $122.00 to $123.00 and gave the company an “outperform” rating in a research report on Tuesday, October 28th. Six research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $113.91.

Institutional Trading of Revvity

A number of hedge funds and other institutional investors have recently modified their holdings of RVTY. CYBER HORNET ETFs LLC bought a new stake in shares of Revvity in the 2nd quarter valued at approximately $32,000. MUFG Securities EMEA plc acquired a new position in Revvity in the second quarter worth $34,000. Headlands Technologies LLC bought a new stake in Revvity during the second quarter valued at $49,000. EverSource Wealth Advisors LLC increased its stake in Revvity by 25.9% during the second quarter. EverSource Wealth Advisors LLC now owns 900 shares of the company’s stock valued at $87,000 after purchasing an additional 185 shares during the last quarter. Finally, Nomura Holdings Inc. acquired a new stake in shares of Revvity during the third quarter worth $270,000. 86.65% of the stock is owned by hedge funds and other institutional investors.

Revvity Company Profile

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.